Preeclampsia affects approximately 5-8% of pregnancies and can lead to severe consequences for both mother and baby if not diagnosed and treated promptly. Biomarkers play a vital role in assessing the risk and progression of preeclampsia, enabling healthcare providers to make informed decisions. Poclight offer cutting-edge solutions that enhance the detection of preeclampsia biomarkers. Uti...
The Clinical Significance of Preeclampsia Biomarkers and Our Innovative Solutions
